U.S. Seeks to Pause J&J Covid-19 Vaccine Use Amid Blood Clotting Reports -- Update
April 13 2021 - 8:11AM
Dow Jones News
By Peter Loftus
U.S. health authorities recommended a pause in the use of
Johnson & Johnson's Covid-19 vaccine in order to investigate
rare but severe cases of blood clots.
The U.S. Food and Drug Administration and the U.S. Centers for
Disease Control and Prevention announced the move Tuesday, after
finding that six women between the ages of 18 and 48 years who got
the vaccine had developed blood clots.
A panel of outside experts will meet Wednesday to review the
matter for the CDC, while the FDA will also conduct an
investigation.
J&J's vaccine was the third authorized for use in the U.S.
It uses the same technology as a vaccine from AstraZeneca PLC and
the University of Oxford, not yet authorized in the U.S. that has
also been linked to rare cases of blood clots.
Write to Peter Loftus at peter.loftus@wsj.com
(END) Dow Jones Newswires
April 13, 2021 07:56 ET (11:56 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024